News
-
-
-
COMMUNIQUÉ DE PRESSE
Monogram Technologies Provides 510(k) Submission Update Following Positive Meeting with FDA
Monogram Technologies Inc. provides update on FDA Submission Issue Request (SIR) meeting, aiming to address FDA's concerns without needing clinical data. Management anticipates a comprehensive AIR response in Q1 2025 -
-
-
COMMUNIQUÉ DE PRESSE
Monogram Technologies Announces Management and Related Parties Complete Open Market Purchases of MGRM Common Stock Totaling $1 Million
Monogram Technologies Inc. announces $1 million in common stock purchases by senior management, highlighting confidence in strategy and future growth. Upcoming milestones include FDA meetings and expansion of international relationships -
-
-
COMMUNIQUÉ DE PRESSE
Monogram Technologies Reports Third Quarter 2024 Financial Results
Monogram Technologies Inc. closed an oversubscribed $13 million public offering to fund near-term commercialization milestones. Submitted a 510(k) premarket filing, received an AIR from the FDA, and secured a strategic collaboration for clinical trials with Shalby Limited -
